Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-25-013648
Filing Date
2025-09-16
Accepted
2025-09-16 10:19:47
Documents
14
Period of Report
2025-09-11
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A form8-ka.htm   iXBRL 8-K/A 55771
2 EX-3.1 ex3-1.htm EX-3.1 24504
  Complete submission text file 0001493152-25-013648.txt   257180

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE pcsa-20250911.xsd EX-101.SCH 3059
4 XBRL LABEL FILE pcsa-20250911_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE pcsa-20250911_pre.xml EX-101.PRE 22388
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-ka_htm.xml XML 4283
Mailing Address 601 21ST STREET, SUITE 300 VERO BEACH FL 32960
Business Address 601 21ST STREET, SUITE 300 VERO BEACH FL 32960 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

EIN.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39531 | Film No.: 251316091
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)